| 1. |
Arroyo-Johnson C, Mincey KD. Obesity epidemiology worldwide. Gastroenterol Clin North Am, 2016, 45(4): 571-579.
|
| 2. |
Raffaelli M, Sessa L, Mingrone G, et al. Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose? Diabetes Metab Syndr Obes, 2015, 8: 255-262.
|
| 3. |
Rosenthal RJ, International Sleeve Gastrectomy Expert Panel, Diaz AA, et al. International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of >12 000 cases. Surg Obes Relat Dis, 2012, 8(1): 8-19.
|
| 4. |
Ohkuma T, Hirakawa Y, Nakamura U, et al. Association between eating rate and obesity: a systematic review and meta-analysis. Int J Obes (Lond), 2015, 39(11): 1589-1596.
|
| 5. |
Braghetto I, Davanzo C, Korn O, et al. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg, 2009, 19(11): 1515-1521.
|
| 6. |
Melissas J, Leventi A, Klinaki I, et al. Alterations of global gastrointestinal motility after sleeve gastrectomy: a prospective study. Ann Surg, 2013, 258(6): 976-982.
|
| 7. |
Pomerri F, Foletto M, Allegro G, et al. Laparoscopic sleeve gastrectomy—radiological assessment of fundus size and sleeve voiding. Obes Surg, 2011, 21(7): 858-863.
|
| 8. |
Deguines JB, Verhaeghe P, Yzet T, et al. Is the residual gastric volume after laparoscopic sleeve gastrectomy an objective criterion for adapting the treatment strategy after failure? Surg Obes Relat Dis, 2013, 9(5): 660-666.
|
| 9. |
Holinski F, Menenakos C, Haber G, et al. Olfactory and gustatory function after bariatric surgery. Obes Surg, 2015, 25(12): 2314-2320.
|
| 10. |
Makaronidis JM, Batterham RL. Potential mechanisms mediating sustained weight loss following Roux-en-Y gastric bypass and sleeve gastrectomy. Endocrinol Metab Clin North Am, 2016, 45(3): 539-552.
|
| 11. |
Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev, 2007, 87(4): 1409-1439.
|
| 12. |
Schirra J, Nicolaus M, Roggel R, et al. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans. Gut, 2006, 55(2): 243-251.
|
| 13. |
Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg, 2012, 22(5): 740-748.
|
| 14. |
Chambers AP, Smith EP, Begg DP, et al. Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy. Am J Physiol Endocrinol Metab, 2014, 306(4): E424-E432.
|
| 15. |
Chabot F, Caron A, Laplante M, et al. Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance. World J Diabetes, 2014, 5(3): 328-341.
|
| 16. |
Goitein D, Rubin M. Letter to " Mapping of ghrelin gene expression and cell distribution in the stomach of morbidly obese patients—a possible guide for efficient sleeve gastrectomy construction”—authors’ reply. Obes Surg, 2013, 23(1): 117.
|
| 17. |
Tsoli M, Chronaiou A, Kehagias I, et al. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study. Surg Obes Relat Dis, 2013, 9(5): 667-677.
|
| 18. |
Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature, 2002, 418(6898): 650-654.
|
| 19. |
le Roux CW, Batterham RL, Aylwin SJ, et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology, 2006, 147(1): 3-8.
|
| 20. |
Tan T, Bloom S. Gut hormones as therapeutic agents in treatment of diabetes and obesity. Curr Opin Pharmacol, 2013, 13(6): 996-1001.
|
| 21. |
Tsoli M, Chronaiou A, Kehagias I, et al. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study. Surg Obes Relat Dis, 2013, 9(5): 667-677.
|
| 22. |
Liddle RA. Regulation of cholecystokinin secretion in humans. J Gastroenterol, 2000, 35(3): 181-187.
|
| 23. |
Suzuki K, Simpson KA, Minnion JS, et al. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J, 2010, 57(5): 359-372.
|
| 24. |
Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature, 2006, 444(7121): 854-859.
|
| 25. |
Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin Invest, 2007, 117(1): 24-32.
|
| 26. |
Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg, 2012, 22(5): 740-748.
|
| 27. |
Bertoni AG, Burke GL, Owusu JA, et al. Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care, 2010, 33(4): 804-810.
|
| 28. |
Kelly AS, Ryder JR, Marlatt KL, et al. Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity. Int J Obes (Lond), 2016, 40(2): 275-280.
|
| 29. |
Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med, 2004, 351(25): 2599-2610.
|
| 30. |
Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev, 2005, 26(3): 439-451.
|
| 31. |
Mallipedhi A, Prior SL, Barry JD, et al. Changes in inflammatory markers after sleeve gastrectomy in patients with impaired glucose homeostasis and type 2 diabetes. Surg Obes Relat Dis, 2014, 10(6): 1123-1128.
|
| 32. |
Kelly AS, Ryder JR, Marlatt KL, et al. Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity. Int J Obes (Lond), 2016, 40(2): 275-280.
|
| 33. |
Gómez-Martin JM, Balsa JA, Aracil E, et al. Circulating adiponectin increases in obese women after sleeve gastrectomy or gastric bypass driving beneficial metabolic changes but with no relationship with carotid intima-media thickness. Clin Nutr, 2017 Oct 12. pii: S0261-5614(17)31363-8. doi: 10.1016/j.clnu.2017.10.003. [Epub ahead of print].
|
| 34. |
Roth CL, Kratz M, Ralston MM, et al. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism, 2011, 60(4): 445-452.
|
| 35. |
Engin A. Obesity-associated breast cancer: Analysis of risk factors. Adv Exp Med Biol, 2017, 960: 571-606.
|
1/5
WeChat